| 초록 |
Background: Recently, the renal transplantation for the HLA antibody-sensitized patients has been progressed markedly.
Initially, Our center began to perform renal transplantation for sensitized patients after achieving flow cytometry MFI
ratio less than 2.0 after desensitization using rituximab and plasmapheresis±IVIG. Thereafter, in spite of intensive
desensitization, several patients did not reached MFI ratio less than 2.0. However, we performed renal transplantation
with the agreement of patients under the consideration of reference.
Methods: To desensitize the sensitized patients (originally CDC negative flow cytometry MFI ratio more than 2.0),
plasmapheresis was performed after rituximab 500 mg IV. Patients who showed very high donor specific antibody
titer (MFI ratio >10.0, except one patient), received IVIG. Tacrolimus based triple drug-immunosuppression was
started before 7-10 days of operation except one patient. Basiliximab was administered two times (D0,D4) as for
other usual renal transplant patients. No thymoglobulin was given for the induction therapy.
Results: Nine patients were enrolled between March 2009 and May 2012. Living donor transplantation was performed
for these 9 patients(median age 47.3 years) after plasmapheresis( mean 10.3 times) and rituximab. Five patients
received IVIG for desensitization, and one patient received only two dose of bortezomib perioperatively as a
prophylaxis of antibody mediated rejection. Mean MFI ratio before and after desensitization was 12.5 and 2.42, respectively.
One patient experienced clinically acute antibody mediated rejection which was reversed after one cycle
of bortezomib with postoperative plasmapheresis and IVIG. Other 8 patients did not experience any kind of rejection
so far. After mean follow up of 15.0 months, the renal function is very good without any loss of graft (mean serum
creatinine 1.0) in these 9 patients.
Conclusion: This data shows that patients who have still marginally flow cytometry cross match positive patients after
receiving desensitization could undergo transplantation successfully without heavy dose of postoperative immunosuppression. |